Molecular characterization of a hamster viscerotropic strain of yellow fever virus

Journal of Virology

Volumn 77, Issue 2, 2003, Pages 1462-1468

  McArthur, Monica A ^a,b   Suderman, Miguel T ^a,b   Mutebi, John Paul ^a,b   Xiao, Shu Yuan ^a,b   Barrett, Alan D T ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; HAMSTER; HISTOPATHOLOGY; HOST PATHOGEN INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STRAIN DIFFERENCE; VIREMIA; VIRUS GENOME; VIRUS INFECTION; VIRUS STRAIN; YELLOW FEVER FLAVIVIRUS;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIVIRAL AGENTS; CRICETINAE; FEMALE; GENOME, VIRAL; LIVER; MESOCRICETUS; MUTATION; PROTEIN CONFORMATION; SPLEEN; VIRAL ENVELOPE PROTEINS; YELLOW FEVER VIRUS;

EID: 0037225671     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.2.1462-1468.2003     Document Type: Article

References (35)

1. Barrett, A. D., T. P. Monath, C. B. Cropp, J. A. Adkins, T. N. Ledger, E. A. Gould, J. J. Schlesinger, R. M. Kinney, and D. W. Trent. 1990. Attenuation of wild-type yellow fever virus by passage in HeLa cells. J. Gen. Virol. 71:2301-2306.
2. Barrett, A. D. 1997. Yellow fever vaccines. Biologicals 25:17-25.
3. Cecilia, D., and E. A. Gould. 1991. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 181:70-77.
4. Chan, R. C., D. J. Penney, D. Little, I. W. Carter, J. A. Roberts, and W. D. Rawlinson. 2001. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 358:121-122.
5. Chang, Y. S., C. L. Liao, C. H. Tsao, M. C. Chen, C. I. Liu, L. K. Chen, and Y. L. Lin. 1999. Membrane permeabilization by small hydrophobic nonstructural proteins of Japanese encephalitis virus. J. Virol. 73:6257-6264.
6. Converse, J. L., R. M. Kovatch, J. D. Pulliam, S. C. Nagle, Jr., and E. M. Snyder. 1971. Virulence and pathogenesis of yellow fever virus serially passaged in cell culture. Appl. Microbiol. 21:1053-1057.
7. dos Santos, C. N., P. R. Post, R. Carvalho, I. I. Ferreira, C. M. Rice, and R. Galler. 1995. Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213. Virus Res. 35:35-41.
8. Dunster, L. M., H. Wang, K. D. Ryman, B. R. Miller, S. J. Watowich, P. D. Minor, and A. D. Barrett. 1999. Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus. Virology 261:309-318.
9. Galler, R., K. V. Pugachev, C. L. Santos, S. W. Ocran, A. V. Jabor, S. G. Rodrigues, R. S. Marchevsky, M. S. Freire, L. F. Almeida, A. C. Cruz, A. M. Yamamura, I. M. Rocco, E. S. da Rosa, L. T. Souza, P. F. Vasconcelos, F. Guirakhoo, and T. P. Monath. 2001. Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology 290:309-319.
10. Gao, G. F., M. H. Hussain, H. W. Reid, and E. A. Gould. 1994. Identification of naturally occurring monoclonal antibody escape variants of louping ill virus. J. Gen. Virol. 75:609-614.
11. Hahn, C. S., J. M. Dalrymple, J. H. Strauss, and C. M. Rice. 1987. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc. Natl. Acad. Sci. USA 84:2019-2023.
12. Hasegawa, H., M. Yoshida, T. Shiosaka, S. Fujita, and Y. Kobayashi. 1992. Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology 191:158-165.
13. Hearn, H. J., Jr., W. A. Chappell, P. Demchak, and J. W. Kominik. 1966. Attenuation of aerosolized yellow fever virus after passage in cell culture. Bacteriol. Rev. 30:615-623.
14. Heinz, F. X. 1986. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 31:103-168.
15. Heinz, F. X., and S. L. Allison. 2000. Structures and mechanisms in flavivirus fusion. Adv. Virus Res. 55:231-269.
16. Heinz, F. X., and S. L. Allison. 2001. The machinery for flavivirus fusion with host cell membranes. Curr. Opin. Microbiol. 4:450-455.
17. Holzmann, H., F. X. Heinz, C. W. Mandl, F. Guirakhoo, and C. Kunz. 1990. A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J. Virol. 64:5156-5159.
18. Jennings, A. D., J. E. Whitby, P. D. Minor, and A. D. Barrett. 1993. Comparison of the nucleotide and deduced amino acid sequences of the structural protein genes of the yellow fever 17DD vaccine strain from Senegal with those of other yellow fever vaccine viruses. Vaccine 11:679-681.
19. Jiang, W. R., A. Lowe, S. Higgs, H. Reid, and E. A. Gould. 1993. Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence. J. Gen. Virol. 74:931-935.
20. Lee, E., and M. Lobigs. 2002. Mechanism of virulence attenuation of glycosaminoglycan-binding variants of Japanese encephalitis virus and Murray Valley encephalitis virus. J. Virol. 76:4901-4911.
21. Lobigs, M., R. Usha, A. Nestorowicz, I. D. Marshall, R. C. Weir, and L. Dalgarno. 1990. Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence. Virology 176:587-595.
22. Martin, M., T. F. Tsai, B. Cropp, G. J. Chang, D. A. Holmes, J. Tseng, W. Shieh, S. R. Zaki, I. AI Sanouri, A. F. Cutrona, G. Ray, L. H. Weld, and M. S. Cetron. 2001. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: A report of four cases. Lancet 358:98-104.
23. Monath, T. P., J. Arroyo, I. Levenbook, Z. X. Zhang, J. Catalan, K. Draper, and F. Guirakhoo. 2002. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: Relevance to development and safety testing of live, attenuated vaccines. J. Virol. 76:1932-1943.
24. Mutebi, J. P., H. Wang, L. Li, J. E. Bryant, and A. D. Barrett. 2001. Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa. J. Virol. 75:6999-7008.
25. Qu, L., L. K. McMullan, and C. M. Rice. 2001. Isolation and characterization of noncytopathic pestivirus mutants reveals a role for nonstructural protein NS4B in viral cytopathogenicity. J. Virol. 75:10651-10662.
26. Rey, F. A., F. X. Heinz, C. Mandl, C. Kunz, and S. C. Harrison. 1995. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291-298.
27. Rice, C. M., E. M. Lenches, S. R. Eddy, S. J. Shin, R. L. Sheets, and J. H. Strauss. 1985. Nucleotide sequence of yellow fever virus: Implications for flavivirus gene expression and evolution. Science 229:726-733.
28. Robertson, S. E., B. P. Hull, O. Tomori, J. W. LeDuc, and K. Esteves. 1996. Yellow fever: A decade of reemergence. JAMA 276:1157-1162.
29. Ryman, K. D., T. N. Ledger, R. C. Weir, J. J. Schlesinger, and A. D. Barrett. 1997. Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes. J. Gen. Virol. 78:1353-1356.
30. Ryman, K. D., T. N. Ledger, G. A. Campbell, S. J. Watowich, and A. D. Barrett. 1998. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Virology 244:59-65.
31. Sil, B. K., L. M. Dunster, T. N. Ledger, M. R. Wills, P. D. Minor, and A. D. Barrett. 1992. Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus. J. Virol. 66:4265-4270.
32. Tesh, R. B., H. Guzman, A. P. da Rosa, P. F. Vasconcelos, L. B. Dias, J. E. Bunnell, H. Zhang, and S. Y. Xiao. 2001. Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies. J. Infect. Dis. 183:1431-1436.
33. Vasconcelos, P. F., E. J. Luna, R. Galler, L. J. Silva, T. L. Coimbra, V. L. Barros, T. P. Monath, S. G. Rodigues, C. Laval, Z. G. Costa, M. F. Vilela, C. L. Santos, P. M. Papaiordanou, V. A. Alves, L. D. Andrade, H. K. Sato, E. S. Rosa, G. B. Froguas, E. Lacava, L. M. Almeida, A. C. Cruz, I. M. Rocco, R. T. Santos, O. F. Oliva, and C. M. Papaiordanou. 2001. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: A report of two cases. Lancet 358:91-97.
34. Wang, E., K. D. Ryman, A. D. Jennings, D. J. Wood, F. Taffs, P. D. Minor, P. G. Sanders, and A. D. Barrett. 1995. Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine. J. Gen. Virol. 76:2749-2755.
35. Xiao, S. Y., H. Zhang, H. Guzman, and R. B. Tesh. 2001. Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus). II. Pathology. J. Infect. Dis. 183:1437-1444.